Global Pharmaceutical Solid Dosage Contract Manufacturing Market by Product Type (Tablets, Capsule, Lozenge, Powder, and Others), Drug Releases Pattern(Instant Release, Sustained Release, Extended Release, Effervescent Tablets, Chewable Tablets, Enteric Release),Region– Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Description

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Overview

Pharmaceutical solid dosage forms are commonly used drug delivery methods across the patient groups. Pharmaceuticals solid dosage contract manufacturing is dominating the pharmaceutical formulations due to rising popularity and increase in the adoption rate by the pharmaceutical companies. The solid dosage formations are manufactured and are available in variants such as capsule, tablets, lozenge, etc. The Pharmaceutical manufacturing unit is looking forward for outsourcing of drug formulation, i.e., Contract Manufacturing Organization. A contract manufacturing organization (CMO) is an organization that serves the pharmaceutical industry and provides clients with comprehensive services, from drug development to manufacturing. Outsourcing to a CMO allows the pharmaceutical clients to expand the technical resources, without increased overhead and achieve economies of scale.

The Contract Manufacturing Organization (CMO) is expected to reach USD 162.1 billion by 2025 at a CAGR of 6.4% due to driving factors such as increasing demand for generic medicines, complex requirement for manufacturing, etc. The Pharmaceutical solid dosage contract manufacturing market is expected to grow in terms of revenue in the near future due to growth drivers such as fixed dose combination, releasing drug pattern, increasing patients, etc.

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Growth Drivers

The pharmaceutical solid dosage provides improved efficiency, minimized cost of drug formulation, which is boosting the global pharmaceutical solid dosage contract manufacturing market. CMO (contract Manufacturing Outsourcing) will be beneficial for pharmaceutical companies due to growing capital intensive nature of the business as CMO will ensure business continuity, risk mitigation. Rising Popularity, advance technology, increased governmental supports are driving the pharmaceutical solid dosage contract manufacturing market globally. Factors such as unavailability of trained staff, capacity of the equipment will act as a hindrance in the growth of pharmaceutical solid dosage contract manufacturing market. The Covid-19 has impacted the healthcare sector positively by shifting the focus of people towards the importance of healthcare. Government’s initiative to provide effective treatment to patients suffering with the infection has proved to be a recreation of medical priorities across healthcare institutions. This will result in the growth of the Pharmaceutical Solid Dosage Contract Manufacturing market in the next coming years.

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Segmentation

Global pharmaceutical solid dosage contract manufacturing market is bifurcated into product type, drug releases pattern and region. Based on the product type, the global pharmaceutical solid dosage contract manufacturing market is categorized into Tablets, Capsule, Lozenge, Powder, and Others. Based on the drug releases pattern, the global pharmaceutical solid dosage contract manufacturing market is split into Instant Release, Sustained Release, Extended Release, Effervescent Tablets, Chewable Tablets, and Enteric Release. By region, the global pharmaceutical solid dosage contract manufacturing market is segmented into Middle East and Africa, Asia Pacific, North America, Eastern Europe, Latin America, and Western Europe.

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Regional Analysis

The global pharmaceutical solid dosage contract manufacturing market is dominating the market in North America followed by Europe due to driving factors such as advancement in technology, improved healthcare infrastructure and the increased research and development activities in the market of pharmaceuticals. CMO has also contributed in the region’s market by investing in the new technologies and facilities by introducing distributed manufacturing to take manufacturing closer to the patient, and adopting continuous manufacturing and digitization of processes. For example, CMOs are partnering with third-party vendors for layered analytics with the aim of optimizing processes, introducing preventive maintenance, and making supply chains transparent. Rising number of companies outsourcing the projects in the developing economies of this region has also ensured the growth of the market. Owing to the increased initiatives by the Asia Pacific government and adoption of advance technologies, the global pharmaceutical solid dosage contract manufacturing market will be growing rapidly in the next coming years.

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Competitive Players

Key players in the global pharmaceutical solid dosage contract manufacturing market include HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions, Althea Technologies, Jubilant Life Sciences Limited, Royal DSM N.V and Nipro Corp. Aenova, Alkermes plc, Associates of Cape Cod Inc., BioPharma Solutions, , Coldstream Laboratories Inc., Covance Inc., Cytovance Biologics, Inc., Dalton Pharma Services, DPT Laboratories, Emergent BioSolutions Inc., Fresenius Kabi, Grand River Aseptic Manufacturing (GRAM), Halo Pharmaceutical, IGI Laboratories, Lyophilization Technology, Inc., Metrics Inc., Mikart, Inc., Patheon, Inc., Pillar5 Pharma Inc., and Velesco Pharma, etc. The key players are strategizing for industry consolidation between Contract Manufacturing Organization, Pharmaceuticals, and Biotech companies which will result in the growth of the CMOs market for solid dosage formulation. The companies are also expanding their products through acquisitions.

Global Pharmaceutical Solid Dosage Contract Manufacturing Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter 1.Preface
  • 1.1.Report Description
  • 1.2.Report Scope
• Chapter 2.Research Methodulogy
  • 2.1.Research Methodulogy
  • 2.2.Secondary Research
  • 2.3.Primary Research
  • 2.4.Models
    • 2.4.1.Company Share Analysis Model
    • 2.4.2.Revenue Based Modeling
  • 2.5.Research Limitations
• Chapter 3.Executive Summary
  • 3.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market, 2016 – 2026 (USD MILLION)
  • 3.2.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market: Snapshot
• Chapter 4.Pharmaceutical Sulid Dosage Contract Manufacturing Market – Industry Analysis
  • 4.1.Introduction
  • 4.2.Market Drivers
    • 4.2.1.Driving Factor 1 Analysis
    • 4.2.2.Driving Factor 2 Analysis:
  • 4.3.Market Restraints
    • 4.3.1.Restraining Factor Analysis
  • 4.4.Market Opportunities
    • 4.4.1.Market Opportunity & Use-case Anaysis
    • 4.4.2.Use – Cases for Pharmaceutical Sulid Dosage Contract Manufacturing
  • 4.5.Porter’s Five Forces Analysis
  • 4.6.COVID 19 Impact Analysis
    • 4.6.1.1.Impact on Product Development and Technulogy Adoption
    • 4.6.1.2.Gap Analysis

• Chapter 5.Investment Proposition Analysis
  • 5.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Attractiveness, By Product Type
  • 5.2.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Attractiveness, By Drug Releases Pattern
  • 5.3.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Attractiveness, By Region
• Chapter 6.Competitive Landscape
  • 6.1.Company Market Share Analysis - 2019
    • 6.1.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market: Company Market Share, 2019
  • 6.2.Strategic Developments
  • 7.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Overview: by Product Type
    • 7.1.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue Share, by Product Type, 2019 & 2026
  • 7.2.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Analysis/Overview – By Product Type
    • 7.2.1.Tablets – Overview/Analysis
    • 7.2.2.Capsule – Overview/Analysis
    • 7.2.3.Lozenge – Overview/Analysis
    • 7.2.4.Powder – Overview/Analysis
    • 7.2.5.Others – Overview/Analysis
  • 7.3.Tablets
    • 7.3.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Tablets, Revenue (USD MILLION) 2016 - 2026
  • 7.4.Capsule
    • 7.4.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Capsule, Revenue (USD MILLION) 2016 - 2026
  • 7.5.Lozenge
    • 7.5.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Lozenge, Revenue (USD MILLION) 2016 - 2026
  • 7.6.Powder
    • 7.6.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Powder, Revenue (USD MILLION) 2016 - 2026
  • 7.7.Others
    • 7.7.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Others, Revenue (USD MILLION) 2016 - 2026
  • 8.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Overview: by Drug Releases Pattern
    • 8.1.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue Share, by Drug Releases Pattern, 2019 & 2026
  • 8.2.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Analysis/Overview – By Drug Releases Pattern
    • 8.2.1.Instant Release – Overview/Analysis
    • 8.2.2.Sustained Release – Overview/Analysis
    • 8.2.3.Extended Release – Overview/Analysis
    • 8.2.4.Effervescent Tablets – Overview/Analysis
    • 8.2.5.Chewable Tablets – Overview/Analysis
    • 8.2.6.Enteric Release – Overview/Analysis
  • 8.3.Instant Release
    • 8.3.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Instant Release, Revenue (USD MILLION) 2016 - 2026
  • 8.4.Sustained Release
    • 8.4.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Sustained Release, Revenue (USD MILLION) 2016 - 2026
  • 8.5.Extended Release
    • 8.5.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Extended Release, Revenue (USD MILLION) 2016 - 2026
  • 8.6.Effervescent Tablets
    • 8.6.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Effervescent Tablets, Revenue (USD MILLION) 2016 - 2026
  • 8.7.Chewable Tablets
    • 8.7.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Chewable Tablets, Revenue (USD MILLION) 2016 - 2026
  • 8.8.Enteric Release
    • 8.8.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market for Enteric Release, Revenue (USD MILLION) 2016 - 2026
• Chapter 9.Pharmaceutical Sulid Dosage Contract Manufacturing Market – Regional Analysis
  • 9.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market: Regional Overview
    • 9.1.1.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue Share, by Region, 2019 & 2026
    • 9.1.2.Global Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Region, 2016 – 2026 (USD MILLION)
  • 9.2.North America
    • 9.2.1.North America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, 2016 - 2026 (USD MILLION)
    • 9.2.2.North America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Country, 2016 – 2026 (USD MILLION)
    • 9.2.3.North America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Product Type, 2016 – 2026
    • 9.2.4.North America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Drug Releases Pattern, 2016 – 2026
    • 9.2.5. U.S.
    • 9.2.6.Canada
  • 9.3.Europe
    • 9.3.1.Europe Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, 2016 - 2026 (USD MILLION)
    • 9.3.2.Europe Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Country, 2016 – 2026 (USD MILLION)
    • 9.3.3.Europe Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Product Type, 2016 – 2026
    • 9.3.4.Europe Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Drug Releases Pattern, 2016 – 2026
    • 9.3.5.Germany
    • 9.3.6.France
    • 9.3.7. U.K.
    • 9.3.8.Italy
    • 9.3.9.Spain
    • 9.3.10.Rest of Europe
  • 9.4.Asia Pacific
    • 9.4.1.Asia Pacific Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, 2016 - 2026 (USD MILLION)
    • 9.4.2.Asia Pacific Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Country, 2016 – 2026 (USD MILLION)
    • 9.4.3.Asia Pacific Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Product Type, 2016 – 2026
    • 9.4.4.Asia Pacific Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Drug Releases Pattern, 2016 – 2026
    • 9.4.5.China
    • 9.4.6.Japan
    • 9.4.7.India
    • 9.4.8.South Korea
    • 9.4.9.South-East Asia
    • 9.4.10.Rest of Asia Pacific
  • 9.5.Latin America
    • 9.5.1.Latin America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, 2016 - 2026 (USD MILLION)
    • 9.5.2.Latin America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Country, 2016 – 2026 (USD MILLION)
    • 9.5.3.Latin America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Product Type, 2016 – 2026
    • 9.5.4.Latin America Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Drug Releases Pattern, 2016 – 2026
    • 9.5.5.Brazil
    • 9.5.6.Mexico
    • 9.5.7.Rest of Latin America
  • 9.6.The Middle-East and Africa
    • 9.6.1.The Middle-East and Africa Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, 2016 - 2026 (USD MILLION)
    • 9.6.2.The Middle-East and Africa Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Country, 2016 – 2026 (USD MILLION)
    • 9.6.3.The Middle-East and Africa Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Product Type, 2016 – 2026
    • 9.6.4.The Middle-East and Africa Pharmaceutical Sulid Dosage Contract Manufacturing Market Revenue, by Drug Releases Pattern, 2016 – 2026
    • 9.6.5.GCC Countries
    • 9.6.6.South Africa
    • 9.6.7.Rest of Middle-East Africa
• Chapter 10.Company Profiles
  • 10.1.HAUPT Pharma AG
    • 10.1.1.Company Overview
    • 10.1.2.Financial Overview
    • 10.1.3.Product Portfulio
    • 10.1.4.Business Strategy
    • 10.1.5.Recent Developments
  • 10.2.Abbott Laboratories
  • 10.3.NextPharma
  • 10.4.Catalent Pharma Sulutions
  • 10.5.Althea Technulogies
  • 10.6.Jubilant Life Sciences Limited
  • 10.7.Royal DSM N.V and Nipro Corp. Aenova
  • 10.8.Alkermes plc
  • 10.9.Associates of Cape Cod Inc.
  • 10.1.BioPharma Sulutions
  • 10.11.Culdstream Laboratories Inc.
  • 10.12.Covance Inc.
  • 10.13.Cytovance Biulogics
  • 10.15.Dalton Pharma Services, Inc.
  • 10.16.DPT Laboratories
  • 10.17.Emergent BioSulutions Inc.
  • 10.18.Fresenius Kabi
  • 10.19.Grand River Aseptic Manufacturing (GRAM)
  • 10.2.Halo Pharmaceutical
  • 10.21.IGI Laboratories
  • 10.22.Lyophilization Technulogy, Inc.
  • 10.24.Metrics Inc.
  • 10.25.Mikart, Inc.
  • 10.27.Patheon, Inc.
  • 10.29.Pillar5 Pharma Inc.
  • 10.3.Velesco Pharma

Methodology